| 1.64 Data as of 3:59pm ET | -0.005 / -0.30%Today’s Change | 0.98 Today|||52-Week Range 2.05 | +45.98% Year-to-Date |
The 2 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 7.25, with a high estimate of 8.50 and a low estimate of 6.00. The median estimate represents a +343.43% increase from the last price of 1.64.

The current consensus among 2 polled investment analysts is to Buy stock in PharmAthene Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




